Research And Markets Research And Markets
0 CHECKOUT

The Corporate Reputation of Pharma - The Patient Perspective in 2015 - Global Edition

  • ID: 3641724
  • March 2016
  • Region: Global
  • 185 pages
  • PatientView
1 of 4
Only 15% of the Patient Groups Responding to the 2015 Survey Stated that Pharma was “Excellent” or “Good” at Having Fair Pricing Policies

FEATURED COMPANIES

  • AbbVie
  • Baxalta
  • Eisai
  • GSK
  • Merck & Co
  • Pfizer
  • MORE

This report is based on the findings of a survey that was done between November 2015 - January 2016 exploring the views of 1,075 patient groups from 72 countries, and focusing on differing medical specialties. The report provides feedback on the corporate reputation of the pharma industry during 2015, as well as the performance of 48 pharma companies for six key indicators that influence corporate reputation. Results are compared with those of the previous four years.

“Large patient organisations (such as CHSG.org) should bepart of pharma’s business relationships, providing direct patient feedback in a cohesive way, helping to identify research opportunities, and also helping to design and populate trials. ...We at CHSG.org seek to partner with pharma to help drive new opportunities, research targets, even aggregate analysis of anecdotal data, and, of course, new study design and enrolment...Well-formed and respected patient-community non-profits offer a world of information that can significantly benefit pharma. They do more than support. Not only do they have the benefit of patient experience, they have input from every patient’s doctors, around the globe. They are, in fact, experts in their disease—in what works, what doesn’t, and even in the root causes and the mechanisms of activation.”

- Comment by an international, US-based patient organisation specialising in headaches [source: ‘Corporate Reputation of Pharma’ survey, November 2015-January 2016]

Profiles of the 48 companies, according to the patient groups familiar with these companies or have worked with them.

Each profile contains:
COMPANY BACKGROUND INFORMATION
- Annual revenue (latest-available year), comprising amount in currency, READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie
  • Baxalta
  • Eisai
  • GSK
  • Merck & Co
  • Pfizer
  • MORE

INTRODUCTION

WHAT HAPPENED IN 2015:
- How the 2015 activities of pharma influence patient-group thinking
- Patient groups and their working relationships with pharma
- Industry-wide implications of patient-group feedback 2015
- What can pharma companies do to improve their corporate reputation?

METHODOLOGY OF PATIENT-GROUP SURVEY

QUESTIONNAIRE FOR PHARMA COMPANIES

APPENDIX 1:
- Data on how patient groups see the pharmaceutical industry worldwide in 2015, and in previous years

APPENDIX 2:
- Rankings of the 48 pharma companies for each of the 6 indicators of corporate reputation, as perceived by patient groups in 2015, compared with 2014
- The three tiers of pharma companies (according to patient groups)
- Details for each of the 48 companies on the extent to which the patient groups they work with also work with other companies

APPENDIX 3:
- Profiles of the 48 companies

APPENDIX 4:
- Profiles of the 1,075 respondent patient groups

LIST OF TABLES AND CHARTS
- Scale of importance of patient-advocacy groups (PAGs) to ten pharma companies
- Percentage of patient groups claiming familiarity with the company
- Percentage of patient groups claiming familiarity, and which also worked with the company
- With how many pharma companies do patient groups work?
- % of patient groups believing that the corporate reputation of the pharma industry had IMPROVED over the past five years (data for 2011 to 2015)
- % of patient groups believing that the corporate reputation of the pharma industry had DECLINED over the past five years (data for 2011 to 2015)
- Percentage of patient groups, by specialty, stating that pharma is “POOR” at having FAIR PRICING POLICIES
- Percentage of patient groups, by geographic region, stating that pharma is “POOR” at having FAIR PRICING POLICIES
- Percentage of patient groups, by specialty, stating that pharma is “POOR” at TRANSPARENCY
- Percentage of patient groups, by geographic region, stating that pharma is “POOR” at TRANSPARENCY
- If a pharma company wishes to improve its corporate reputation with patients and patient groups, which single strategy from the list below do you think would be MOST IMPORTANT for the company to follow? Please select only ONE option
- How do you think your organisation's members (or the people you represent) would rate the corporate reputation of the following healthcare sectors in 2014?
- How do you think your organisation's members (or the people you represent) would rate the corporate reputation of the following healthcare sectors in 2014?
- How do you think your organisation’s members (or the people you represent) would rate the corporate reputation of pharma? (Data for 2011 to 2015)
- How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)?
- How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)? (Year-on-year comparators, 2011-2015)
- Companies with the most effective patient-centred strategy (rankings of 48 companies, 2015; rankings of 37 companies, 2014)
- Companies providing the best high-quality patient information (rankings of 48 companies, 2015; rankings of 37 companies, 2014)
- Companies with the best record on patient safety (rankings of 48 companies, 2015; rankings of 37 companies, 2014)
- Companies with the most-useful high-quality products (rankings of 48 companies, 2015; rankings of 37 companies, 2014)
- Companies with the best record of transparency (rankings of 48 companies, 2015; rankings of 37 companies, 2014)
- Companies with the best record on integrity (rankings of 48 companies, 2015; rankings of 37 companies, 2014)
- Rankings of the 48 pharmaceutical companies in 2015, ALPHABETIC ORDER
- Rankings of the 48 pharmaceutical companies in 2015, HIGHEST TO LOWEST
- Rankings of the 48 pharmaceutical companies in 2015, FALLING INTO THREE CLEAR TIERS
- Percentage of patient groups working with other companies

Note: Product cover images may vary from those shown
3 of 4

- AbbVie
- Actavis
- Allergan
- Almirall
- Amgen
- Astellas Pharma
- AstraZeneca
- Baxalta
- Bayer
- Biogen Idec
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Celgene
- Chiesi Farmaceutici
- Eisai
- Eli Lilly (Lilly)
- Ferring
- GSK
- Gedeon Richter
- Gilead Sciences
- Grifols
- Grünenthal
- Hospira
- Ipsen
- Janssen Pharmaceutical Companies of Johnson & Johnson
- LEO Pharma
- Lundbeck
- Mallinckrodt
- Menarini
- Merck & Co
- Merck KGaA
- Mylan
- Novartis
- Novo Nordisk
- Octapharma
- Otsuka
- Pfizer
- Roche
- Sandoz
- Sanofi
- Servier
- Shire
- Stada Arzneimittel
- Takeda
- Teva
- UCB
- Valeant
- ViiV Healthcare

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

RELATED PRODUCTS from Cache